biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	5F48212D-0EC9-4344-B3DC-E9B0E3C7DAFC
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A11D-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A11D-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A11D-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433563
biospecimen__bio__day_of_creation	16
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A11D.8D1A74F7-E6C3-4557-917A-CA7273929ADF.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	F
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A11D
biospecimen__shared__patient_id	A11D
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A11D-A43743
clinical__ablation__bcr_ablation_uuid	1BD30F5B-B70D-4E68-8C90-E6658939E2A4
clinical__ablation__days_to_embolization_performed	1506
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	Y90 Theraspheres
clinical__ablation__embolization_type	Radioembolization
clinical__ablation__embolizing_agent_utilized	Y-90 Therasphere
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	3F83EE20-FBF7-4EBF-997F-4BC273051548
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	8
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	57
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A11D-F38787
clinical__clin_shared__bcr_followup_uuid	52047B14-703B-43D5-BA06-2FA783E14E20
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Partial Response
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	249
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2006
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	498
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Lung
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_neoplasm_occurrence_anatomic_site_text	anterior abdominal wall
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A11D-D43741
clinical__rx__bcr_drug_uuid	4BBDB795-AA63-453D-88B3-677EB922902E
clinical__rx__days_to_drug_therapy_end	1105
clinical__rx__days_to_drug_therapy_start	1408
clinical__rx__drug_name	Temozolomide
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	83f00aa4-635f-4bf6-b3ec-ebf8ccbdf43f
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A11D-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	6bd26578-cdc6-466f-9f7e-1b395ad4ce2c
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.83
gdc__analytes__analyte_id	7c91f5c4-cd12-4f4d-bec6-d18214d738a5
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	0ef95351-0133-4f34-a59c-90934fb161f8
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:40:54.554160-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	37da8f10-1df1-5744-9241-3da1b200392f
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1949
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	21003
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-21003.0
gdc__diagnoses__days_to_death	1560.0
gdc__diagnoses__diagnosis_id	cab20d99-084b-5327-9457-c7f7898a4254
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	27.475629493018175
gdc__exposures__exposure_id	84abd4cc-9b7e-517b-b8e6-fbfbfc9d31f9
gdc__exposures__height	163.0
gdc__exposures__weight	73.0
gdc__file_id	349b5262-bc60-47d0-8c1f-36990f455ffe
gdc__file_name	b9c836ee-4178-4200-a770-df35e8b108d8.mirbase21.mirnas.quantification.txt
gdc__file_size	50305
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	40639678d1b06d73d718902a6c47bff0
gdc__portions__is_ffpe	false
gdc__portions__portion_id	681112d8-57db-4b32-b44e-3ead64b2f691
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1731
gdc__samples__initial_weight	300.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	8D1A74F7-E6C3-4557-917A-CA7273929ADF
gdc__samples__sample_id	f1fa4bcc-bcac-4174-984c-f057af2b9826
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	2.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	75.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	84c56bd1-40e0-426d-aa2d-4faca21b4821
gdc__submitter_id	mirna_swap_dr11_306_MirnaExpression1d627aaf-ef57-4b64-8611-3a465b9d1cca_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	f6811cde-dd6d-54f1-9a1d-ab1adc193bfb
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:45.504+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/83f00aa4-635f-4bf6-b3ec-ebf8ccbdf43f-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/83f00aa4-635f-4bf6-b3ec-ebf8ccbdf43f-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129676
manually_curated__local_md5	e73d97406b014728f43f7bb16549d6aa
manually_curated__opengdc_download_date	2018-10-16T17:12:25.000090+02:00
manually_curated__opengdc_file_md5	f05a813b21c907878fb9b41b47a4248b
manually_curated__opengdc_file_size	50304
manually_curated__opengdc_id	83f00aa4-635f-4bf6-b3ec-ebf8ccbdf43f-meq
manually_curated__origin_file_size	129676
manually_curated__origin_last_modified_date	Tue Oct 16 17:43:00 CEST 2018
manually_curated__origin_md5	e73d97406b014728f43f7bb16549d6aa
manually_curated__tissue_status	tumoral
